Wednesday, January 18, 2012

Free 30-Day Access & Insider Coverage of JPM

Having trouble viewing images? View in web browser

Flagship closes $270M fund for early stage investments ... Regenerative medicine is rapidly moving from lab to clinic ... Arena back on track with a $33M equity financing ... Funding aplenty, China is seeking innovation ... Regulatory inconsistency, missed handoffs threaten innovation ... Sernova cuts through ‘valley of death’ at JPM.

This is just a sampling of what BioWorld Today subscribers have read about in their recent issues. Click here or on the sample issue to the right to read more on the stories above. Then sign up for your 30-day risk-free access!

Delivered to your desktop every single business morning, BioWorld Today includes coverage of: 

  • Therapeutic product development from early to late stage
  • Strategic alliances, mergers and acquisitions
  • Corporate financings, both public and private
  • Biotech company advancements and setbacks
  • Scientific milestones
  • Global regulatory updates
  • Profiles of new and mature biotech and specialty pharmaceutical firms
  • Big pharma’s growing involvement in biotech

You’ll get the inside track on what your competitors are doing; where top investors are placing their bets and who’s raising funds; the latest technological innovations; what the FDA and Congress are up to and much more.

With an international team of writers and editors, BioWorld Today provides the critical news and insights you need to stay competitive in this industry!

Try out BioWorld Today for 30 days absolutely FREE!

 

Sign Up Today for a 30-Day Risk-Free Trial

Questions or comments call Customer Service at 404-262-5547.

Get Connected!

Our Blog Twitter RSS Feed LinkedIn Facebook

 

BioWorld | 3525 Piedmont Road, Building 6, Suite 400 | Atlanta, GA 30305

You are receiving this email because you previously purchased products or indicated you wanted to be informed of the latest news and specials from BioWorld. This is an advertising email. This message was intended for: {{lead.Email Address:default=email}}. You can manage your subscription here or if you prefer not to receive future emails from BioWorld, you can unsubscribe here.

BioSpace

You have received this email because you registered at BioSpace. BioSpace regularly sends emails to active subscribers on behalf of our advertising partners or to promote our own products and services.

If you would like to stop receiving all email communications from BioSpace, you can unsubscribe at any time by clicking here.

BioSpace
6465 South Greenwood Plaza, Suite 400, Centennial, CO 80111, U.S.
(888) BIOSPACE


No comments: